Skip to main content
DNA Labs India

Epilepsy Day 2026: The Transformative Power of Genetic Testing in Epilepsy Management

Genomic & Hereditary Oncology | DNA Labs India

Genomic & Hereditary Oncology

Epilepsy Day 2026: The Transformative Power of Genetic Testing in Epilepsy Management

Discover how NGS genetic testing revolutionizes epilepsy diagnosis and treatment. Learn about the Epilepsy Panel test at DNA Labs India – ISO 9001 certified.

NeurologistGenomic & Hereditary Oncology
Written by: Lookesh SharmaMedically Reviewed by: Dr Vasudeva Rao Pandurangi Sanyasi, MBBS, MD (Neurology)Last Updated: September 09, 2026

At a Glance: Epilepsy Panel NGS Genetic Test

  • Sample Required: Blood, Extracted DNA, or Blood on FTA Card
  • Fasting Rules: Not required
  • Turnaround Time (TAT): 3–4 weeks
  • Base Cost: ₹20,000 (discounted from ₹30,000)

Written by: Dr. A. Sharma, MD (Neurology) | Medically Reviewed by: Dr. R. Iyer, PhD (Medical Genetics) | Last Updated: February 2026

50+ MillionPeople Affected Worldwide
10 MillionCases in India
30–40%Genetic Involvement

As International Epilepsy Day 2026 approaches, the global medical community focuses not only on raising awareness but also on celebrating groundbreaking diagnostic advancements. The integration of Next-Generation Sequencing (NGS) genetic testing into epilepsy care represents a paradigm shift, offering hope for more precise diagnoses and personalized treatment strategies for millions affected by this neurological disorder.

Understanding Epilepsy: More Than Just Seizures

Epilepsy is a chronic neurological condition characterized by recurrent, unprovoked seizures caused by sudden electrical disturbances in the brain. These seizures manifest in diverse ways, ranging from brief absence spells to full-body convulsions, making epilepsy a spectrum disorder rather than a single condition. Beyond the physical manifestations, individuals with epilepsy often face cognitive challenges, emotional health issues, and significant social stigma that can impact their quality of life as much as the seizures themselves.

The Genetic Revolution in Epilepsy Understanding

Recent scientific breakthroughs have illuminated the substantial role genetics plays in epilepsy. Approximately 30–40% of epilepsy cases have an identifiable genetic component, with hundreds of genes potentially contributing to various forms of the disorder. These genetic variations can affect brain cell communication, electrical regulation, and structural development.

Key Genetic Pathways in Epilepsy

  • Ion Channel Genes (SCN1A, SCN2A, KCNQ2, KCNQ3): Affect electrical signaling in neurons
  • MTOR Pathway Genes (DEPDC5, TSC1, TSC2): Regulate cell growth and metabolism
  • Transcriptional Regulators (CDKL5, MECP2): Associated with severe early-onset epilepsies
  • Cell Adhesion Molecules (PCDH19): Implicated in epilepsy predominantly affecting females
  • Neurotransmitter-Related Genes (GABRG2, GABRA1): Affect inhibitory signaling in the brain

Comprehensive Gene Analysis: The Epilepsy Panel NGS Genetic Test analyzes over 600 genes associated with epilepsy, including AARS1, ABCD1, ACAD9, ALDH7A1, ARX, CACNA1A, CDKL5, DEPDC5, EEF1A2, GABRG2, KCNQ2, MECP2, PCDH19, SCN1A, SCN2A, STXBP1, TSC1, TSC2, UBE3A, and hundreds more relevant to seizure disorders and related neurological conditions.

The Epilepsy Panel NGS Genetic Test: Precision Diagnostics

DNA Labs India offers a comprehensive Epilepsy Panel NGS Genetic Test that utilizes cutting-edge next-generation sequencing technology to identify genetic variants associated with epilepsy. This test provides crucial information that can guide treatment decisions, inform prognosis, and offer answers to families who have struggled with diagnostic uncertainty.

Test Specifications & Pricing

DetailValue
Test NameEpilepsy Panel NGS Genetic Test
Sample TypeBlood, Extracted DNA, or Blood on FTA Card
MethodologyNext-Generation Sequencing (NGS)
Report Time3–4 Weeks
Original Price₹30,000
Discounted Price₹20,000

Free home sample collection available across 100+ Indian cities including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, Pune, Ahmedabad, and Jaipur.

Who Should Consider Genetic Testing for Epilepsy?

  • Individuals with early-onset epilepsy (beginning in infancy or childhood)
  • Patients with drug-resistant epilepsy unresponsive to standard treatments
  • Those with a strong family history of epilepsy or related neurological conditions
  • Individuals with epilepsy accompanied by developmental delays or intellectual disability
  • Patients whose epilepsy is part of a broader syndrome with multiple symptoms
  • Pregnant women with epilepsy seeking information about inheritance risks

Benefits of Genetic Testing in Epilepsy Management

💡 Key Takeaways

  • This article was written by Lookesh Sharma.
  • Last updated on September 9, 2026. Clinical information is reviewed periodically.
  • Always consult with a qualified healthcare provider before making medical decisions based on the information presented here.

Need Personalized Clinical Guidance?

The information in this article is intended for educational purposes and reflects current scientific understanding. To understand how these insights apply to your specific health profile or family history, speak with a certified genetic counselor at DNA Labs India.

Medical Disclaimer: The clinical insights provided here are intended for educational purposes and do not replace professional medical advice from a primary physician. DNA Labs India is an ISO 9001:2015 certified diagnostic laboratory. Always consult with a qualified healthcare provider regarding any medical concerns, diagnoses, or treatment decisions.

Related Articles in Genomic & Hereditary Oncology

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.